Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial (Q48427388)
scientific article published in October 2009
Language:
Current Data About Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial
(P31) (Q13442814)
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P50) (Q7173149)
(P1545) 4
(P1932) Peter A Calabresi
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018

(Q30353394)
(P1545) 8
(P1932) Emmanuelle Waubant
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018

(Q7609730)
(P1545) 7
(P1932) Stephen Hauser
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P304) 460-471
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P407) (Q1860)

(P433) 4
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P478) 66
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P577) Thursday, October 1, 2009
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P921) (Q18553470)

(Q8277)

(Q269829)
(P887)

(Q6934595)
(P887)

(Q412323)
(P887)

(P1433) (Q564414)
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P1476) "Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial." (language: en)
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P2093) Kathleen Hawker
(P1545) 1
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Paul O'Connor
(P1545) 2
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Mark S Freedman
(P1545) 3
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Jack Antel
(P1545) 5
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Jack Simon
(P1545) 6
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Timothy Vollmer
(P1545) 9
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Hillel Panitch
(P1545) 10
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Jiameng Zhang
(P1545) 11
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Peter Chin
(P1545) 12
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

Craig H Smith
(P1545) 13
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

OLYMPUS trial group
(P1545) 14
(P248)
(P698) 19847908
(P813) Sunday, February 11, 2018
(P854) http://europepmc.org/abstract/MED/19847908

(P2860) (Q48410676)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FANA.21867
(P813) Sunday, January 21, 2018

(Q35891689)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FANA.21867
(P813) Sunday, January 21, 2018

(Q22241644)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FANA.21867
(P813) Sunday, January 21, 2018

other details
description scientific article published in October 2009

External Links
(P356) 10.1002/ANA.21867
(P698) 19847908
(P8608) release_edzoaiqtcvcd7jy65hglf7w3dq